Koga, Kaori
No ORCID on file
· 20 papers in corpus
2024
Additional file 1. The study protocol has been approved by the Clinical Study Review Board of Chiba University Hospital, Chiba, Japan, and registered by the Japan Registry of Clinical Trials (jRCTs032230278, https://jrct.niph.go.jp/ ). An o…
2024
Additional file 1. The study protocol has been approved by the Clinical Study Review Board of Chiba University Hospital, Chiba, Japan, and registered by the Japan Registry of Clinical Trials (jRCTs032230278, https://jrct.niph.go.jp/ ). An o…
2024
Additional file 2. The participant consent form has been approved by the Clinical Study Review Board of Chiba University Hospital, Chiba, Japan, and registered by the Japan Registry of Clinical Trials (jRCTs032230278, https://jrct.niph.go.j…
2024
Additional file 2. The participant consent form has been approved by the Clinical Study Review Board of Chiba University Hospital, Chiba, Japan, and registered by the Japan Registry of Clinical Trials (jRCTs032230278, https://jrct.niph.go.j…
other
2024
Abstract Background Endometriosis-related pain encompassing dysmenorrhea, dyspareunia, and chronic pelvic pain, reduces the quality of life in premenopausal women. Although treatment options for endometriosis alleviate this pain, approximat…
other
2024
Abstract Background Endometriosis-related pain encompassing dysmenorrhea, dyspareunia, and chronic pelvic pain, reduces the quality of life in premenopausal women. Although treatment options for endometriosis alleviate this pain, approximat…
observational
2022
Additional file 1: Fig. S1. Kaplan-Meier survival analysis of endometrial cancer patients. A Progression-free survival rate according to the presence of concomitant endometriosis. B Overall survival rate according to the presence of concomi…
observational
2022
Additional file 1: Fig. S1. Kaplan-Meier survival analysis of endometrial cancer patients. A Progression-free survival rate according to the presence of concomitant endometriosis. B Overall survival rate according to the presence of concomi…
observational
2022
Abstract Background Endometriosis is assumed to be involved in ovarian cancer development, which is called endometriosis-associated ovarian cancer (EAOC). Uterine endometrial cells may be the cell of origin of EAOC. Accumulated carcinogenic…
observational
2022
Abstract Background Endometriosis is assumed to be involved in ovarian cancer development, which is called endometriosis-associated ovarian cancer (EAOC). Uterine endometrial cells may be the cell of origin of EAOC. Accumulated carcinogenic…
diagnostic-accuracy
2019
In cases of extragenital endometriosis or microscopic endometriosis lesions, pathological diagnosis can be challenging because endometriotic stroma and glands represent only a minor component of fibrotic endometriotic lesions. For better ac…
diagnostic-accuracy
2019
In cases of extragenital endometriosis or microscopic endometriosis lesions, pathological diagnosis can be challenging because endometriotic stroma and glands represent only a minor component of fibrotic endometriotic lesions. For better ac…
2019
supplemental_figure_1 - PAX8: A Highly Sensitive Marker for the Glands in Extragenital Endometriosis
supplemental_figure_1 for PAX8: A Highly Sensitive Marker for the Glands in Extragenital Endometriosis by Tomoko Arakawa, Shinya Fukuda, Tetsuya Hirata, Kazuaki Neriishi, Yu Wang, Arisa Takeuchi, Ai Saeki, Miyuki Harada, Yasushi Hirota, Tak…
2019
supplemental_figure_1 - PAX8: A Highly Sensitive Marker for the Glands in Extragenital Endometriosis
supplemental_figure_1 for PAX8: A Highly Sensitive Marker for the Glands in Extragenital Endometriosis by Tomoko Arakawa, Shinya Fukuda, Tetsuya Hirata, Kazuaki Neriishi, Yu Wang, Arisa Takeuchi, Ai Saeki, Miyuki Harada, Yasushi Hirota, Tak…
2019
supplemental_figure_2 - PAX8: A Highly Sensitive Marker for the Glands in Extragenital Endometriosis
supplemental_figure_2 for PAX8: A Highly Sensitive Marker for the Glands in Extragenital Endometriosis by Tomoko Arakawa, Shinya Fukuda, Tetsuya Hirata, Kazuaki Neriishi, Yu Wang, Arisa Takeuchi, Ai Saeki, Miyuki Harada, Yasushi Hirota, Tak…
2019
supplemental_figure_2 - PAX8: A Highly Sensitive Marker for the Glands in Extragenital Endometriosis
supplemental_figure_2 for PAX8: A Highly Sensitive Marker for the Glands in Extragenital Endometriosis by Tomoko Arakawa, Shinya Fukuda, Tetsuya Hirata, Kazuaki Neriishi, Yu Wang, Arisa Takeuchi, Ai Saeki, Miyuki Harada, Yasushi Hirota, Tak…
2019
supplemental_figure_3 - PAX8: A Highly Sensitive Marker for the Glands in Extragenital Endometriosis
supplemental_figure_3 for PAX8: A Highly Sensitive Marker for the Glands in Extragenital Endometriosis by Tomoko Arakawa, Shinya Fukuda, Tetsuya Hirata, Kazuaki Neriishi, Yu Wang, Arisa Takeuchi, Ai Saeki, Miyuki Harada, Yasushi Hirota, Tak…
2019
supplemental_figure_3 - PAX8: A Highly Sensitive Marker for the Glands in Extragenital Endometriosis
supplemental_figure_3 for PAX8: A Highly Sensitive Marker for the Glands in Extragenital Endometriosis by Tomoko Arakawa, Shinya Fukuda, Tetsuya Hirata, Kazuaki Neriishi, Yu Wang, Arisa Takeuchi, Ai Saeki, Miyuki Harada, Yasushi Hirota, Tak…
2019
supplemental_figure_4 - PAX8: A Highly Sensitive Marker for the Glands in Extragenital Endometriosis
supplemental_figure_4 for PAX8: A Highly Sensitive Marker for the Glands in Extragenital Endometriosis by Tomoko Arakawa, Shinya Fukuda, Tetsuya Hirata, Kazuaki Neriishi, Yu Wang, Arisa Takeuchi, Ai Saeki, Miyuki Harada, Yasushi Hirota, Tak…
2019
supplemental_figure_4 - PAX8: A Highly Sensitive Marker for the Glands in Extragenital Endometriosis
supplemental_figure_4 for PAX8: A Highly Sensitive Marker for the Glands in Extragenital Endometriosis by Tomoko Arakawa, Shinya Fukuda, Tetsuya Hirata, Kazuaki Neriishi, Yu Wang, Arisa Takeuchi, Ai Saeki, Miyuki Harada, Yasushi Hirota, Tak…